Inhibition of the expression of ornithine decarboxylase by haloperidol in difluoromethylornithine-resistant leukemia cells

Biochem Pharmacol. 1996 Nov 8;52(9):1393-7. doi: 10.1016/s0006-2952(96)00471-6.

Abstract

In difluoromethylornithine-resistant L1210 cells stimulated to grow from quiescence, haloperidol caused an early and dose-dependent inhibition of the induction of ornithine decarboxylase (ODC) activity, with an IC50 of 3.5 microM. This effect was accompanied by a reduction in the ODC mRNA level and inhibition of cell growth. Other sigma ligands of different chemical classes inhibited the induction of ODC activity, whereas sulpiride, a dopamine antagonist devoid of sigma-binding affinity, was ineffective. These results indicate that the inhibition of ODC expression may be an early event involved in the antiproliferative response of leukemia cells to haloperidol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antipsychotic Agents / pharmacology
  • Cell Division / drug effects
  • Drug Resistance
  • Eflornithine / pharmacology*
  • Enzyme Induction / drug effects
  • Gene Expression / drug effects
  • Haloperidol / pharmacology*
  • Leukemia L1210 / enzymology
  • Leukemia L1210 / genetics
  • Mice
  • Ornithine Decarboxylase / biosynthesis*
  • Ornithine Decarboxylase / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Antineoplastic Agents
  • Antipsychotic Agents
  • RNA, Messenger
  • Ornithine Decarboxylase
  • Haloperidol
  • Eflornithine